As for PTM, Wang et al. (2023) revealed that expression of protein arginine methyltransferase 5 (PRMT5) was positively correlated with Keap1 in breast cancer tissues, and high PRMT5 protein levels suggest that TNBC is highly resistant to immunotherapy. Here, PRMT5 is linked to breast carcinoma.